CEO of top pharma lobby PhRMA to resign: Endpoints News
Source: SeekingAlpha
2026-04-08 12:39:32 ET
More on Big Pharma
- Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030
- Johnson & Johnson: Is The Stock Still Undervalued After The Rally? A Quantitative Approach
- Eli Lilly's Centessa Deal Shows It Is Awake To New Narcolepsy Reality
- RFK Jr. changes rules to select CDC vaccine advisors after legal setback
- GSK gets China approval for Exdensur in nasal polyps, expanding respiratory portfolio
Read the full article on Seeking Alpha
For further details see:
CEO of top pharma lobby PhRMA to resign: Endpoints News
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
